Novo Nordisk, the Danish pharmaceutical giant, has announced an expansion of its partnership with U.S.-based tech firm Valo Health to…
Browsing: Zepbound
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s weight loss drug, Zepbound, for treating moderate-to-severe obstructive sleep…
Nestle (NESN.S), the world’s largest food company, has launched a new product in the United States aimed at weight-loss drug…
Government Programs Drive Access to GLP-1 Drugs State Medicaid programs and federal employee health plans are the leading sources of…
Eli Lilly reported stellar second-quarter earnings, significantly exceeding market expectations, driven by robust sales of its diabetes drug Mounjaro and…
All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the…